argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
630.00
+14.23 (2.31%)
At close: Dec 23, 2024
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
$1,662,595
Profits / Employee
-$35,098
Market Cap
37.92B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
argenx SE News
- 7 days ago - Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval - Benzinga
- 4 weeks ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies - GlobeNewsWire
- 5 weeks ago - Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics - Business Wire
- 5 weeks ago - (ARGX) - Analyzing argenx's Short Interest - Benzinga
- 6 weeks ago - This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 6 weeks ago - Argenx upgraded at Wolfe on myasthenia gravis dominance - Seeking Alpha
- 6 weeks ago - argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China - GlobeNewsWire